It is worth mentioning that FGL1 has been reported to be downregulated in pancreatic, breast, liver, and head and neck cancers, which could be similar to our study due to the location of the rhabdomyosarcoma selected cases [47]. This evidence concerns the gene FGL1 and rhabdomyosarcoma.